This Slide: #8 of 49 |
Slide #8. PhotoMedex — LCA-Vision
Acquirer:
PhotoMedex (PHMD)
Acquiree:
LCA-Vision (LCAV)
Details:
PhotoMedex, Inc. (NasdaqGS and TASE:PHMD) and LCA-Vision, Inc. (NasdaqGS:LCAV) today announced the signing of a definitive agreement pursuant to which PhotoMedex will acquire LCA-Vision for $5.37 per share in cash, or approximately $106.4 million. PhotoMedex is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. LCA-Vision Inc. is a leading provider of laser vision correction services under the LasikPlus brand.
PhotoMedex is in the process of transitioning from a skin health company providing medical and cosmetic solutions for dermatological conditions to a real estate investment company holding investments in a variety of existing and future projects, including residential developments, commercial properties such as gas station sites, and hotels and resort communities.
Open the PHMD Page at The Online Investor »
PhotoMedex is in the process of transitioning from a skin health company providing medical and cosmetic solutions for dermatological conditions to a real estate investment company holding investments in a variety of existing and future projects, including residential developments, commercial properties such as gas station sites, and hotels and resort communities.
Open the LCAV Page at The Online Investor »
|
|
Free Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |